Breast cancer chemoprevention: beyond tamoxifen

C J Fabian1

  • 1University of Kansas Medical Center, Kansas City, Kansas 66160-7320, USA. cfabian@kumc.edu

Insights

New breast cancer chemoprevention agents target molecular abnormalities and offer alternatives to tamoxifen. Biomarkers will refine patient selection and efficacy assessment in clinical trials.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Emerging chemoprevention agents target molecular abnormalities in estrogen receptor (ER)-negative and ER-positive precancerous breast tissue.
  • These agents possess distinct side effect profiles compared to tamoxifen.

Purpose of the Study:

  • To review novel chemoprevention agents and their potential in breast cancer prevention.
  • To discuss the role of biomarkers in optimizing clinical trial design and efficacy assessment.

Main Methods:

  • Review of current and planned clinical prevention trials for breast cancer.
  • Analysis of emerging classes of chemoprevention agents, including selective ER modulators, aromatase inhibitors, and targeted therapies.
  • Evaluation of biomarker strategies for patient selection and response assessment.

Main Results:

  • A diverse array of chemoprevention agents are under investigation, including selective ER modulators, aromatase inactivators, gonadotrophin-releasing hormone agonists, monoterpenes, isoflavones, retinoids, rexinoids, vitamin D derivatives, and inhibitors of tyrosine kinase, cyclooxygenase-2, and polyamine synthesis.
  • New clinical trial models will incorporate morphological and molecular biomarkers for risk stratification, treatment prediction, and efficacy evaluation.

Conclusions:

  • Validated biomarkers could enhance the precision of breast cancer prevention trials, potentially replacing cancer incidence as a primary endpoint.
  • Novel chemoprevention strategies offer promising alternatives with improved safety and efficacy profiles.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...